Dr Evangelos Liberopoulos is an Internist–Lipidologist–Diabetologist. He graduated from the University of Ioannina Medical School, Greece. He specialized in lipid disorders and cardiovascular disease prevention at the Royal Free Hospital, UCL, London, UK, and in diabetes at the Diabetology Centre of ‘Laikon’ General Hospital of Athens. He currently serves as a Professor of Medicine-Metabolic Diseases, School of Medicine, National and Kapodistrian University of Athens, Greece and First Propedeutic Department of Medicine, General Hospital of Athens ‘Laiko’. His main academic and clinical interests include dyslipidemia, diabetes, obesity, and hypertension, as well as acid–base and electrolyte abnormalities. He has published 298 papers in international peer-reviewed journals with 12,745 citations and an H factor of 60 on Google Scholar (2 January 2024). He is a member of the writing committee for guidelines issued by the Hellenic Diabetes Association and the Hellenic Atherosclerosis Society. He has given numerous talks at national and international meetings on topics related to cardiovascular disease prevention. He is currently the National Leader for the HELLAS-FH registry and the National Leader for the VICTORION-1P study. In the past, he was the National Leader for the ODYSSEY-OUTCOMES study. Dr Liberopoulos is an ordinary member of the Executive Committee of the European Atherosclerosis Society (2024–2027).